Risk assessment in pulmonary arterial hypertension

doi:10.1183/13993003.02606-2017

Comment

. 2018 Mar 29;51(3):1702606.

doi: 10.1183/13993003.02606-2017. Print 2018 Mar.

Risk assessment in pulmonary arterial hypertension

Marius M Hoeper^{1

2}, David Pittrow³, Christian Opitz⁴, J Simon R Gibbs⁵, Stephan Rosenkranz^{6

7}, Ekkehard Grünig^{2

8}, Karen M Olsson^{9

2}, Doerte Huscher¹⁰

Affiliations

¹ Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany hoeper.marius@mh-hannover.de.
² German Center of Lung Research (DZL), Germany.
³ Institute for Clinical Pharmacology, Medical Faculty, Technical University, Dresden, Germany.
⁴ Dept of Cardiology, DRK Kliniken Berlin Westend, Berlin, Germany.
⁵ Dept of Cardiology, National Heart and Lung Institute, Imperial College London, London, UK.
⁶ Clinic III for Internal Medicine (Cardiology) and Center for Molecular Medicine (CMMC), University of Cologne, Cologne, Germany.
⁷ The Cologne Cardiovascular Research Center (CCRC), University of Cologne, Cologne, Germany.
⁸ Thoraxclinic at the University Hospital Heidelberg, Heidelberg, Germany.
⁹ Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
¹⁰ Epidemiology Unit, German Rheumatism Research Centre, A. Leibniz Institute, Berlin, Germany.

PMID: 29599117
DOI: 10.1183/13993003.02606-2017

Free article

Comment

Risk assessment in pulmonary arterial hypertension

Marius M Hoeper et al. Eur Respir J. 2018.

Free article

. 2018 Mar 29;51(3):1702606.

doi: 10.1183/13993003.02606-2017. Print 2018 Mar.

Authors

Marius M Hoeper^{1

2}, David Pittrow³, Christian Opitz⁴, J Simon R Gibbs⁵, Stephan Rosenkranz^{6

7}, Ekkehard Grünig^{2

8}, Karen M Olsson^{9

2}, Doerte Huscher¹⁰

Affiliations

¹ Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany hoeper.marius@mh-hannover.de.
² German Center of Lung Research (DZL), Germany.
³ Institute for Clinical Pharmacology, Medical Faculty, Technical University, Dresden, Germany.
⁴ Dept of Cardiology, DRK Kliniken Berlin Westend, Berlin, Germany.
⁵ Dept of Cardiology, National Heart and Lung Institute, Imperial College London, London, UK.
⁶ Clinic III for Internal Medicine (Cardiology) and Center for Molecular Medicine (CMMC), University of Cologne, Cologne, Germany.
⁷ The Cologne Cardiovascular Research Center (CCRC), University of Cologne, Cologne, Germany.
⁸ Thoraxclinic at the University Hospital Heidelberg, Heidelberg, Germany.
⁹ Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
¹⁰ Epidemiology Unit, German Rheumatism Research Centre, A. Leibniz Institute, Berlin, Germany.

PMID: 29599117
DOI: 10.1183/13993003.02606-2017

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: M.M. Hoeper reports receiving personal fees from Actelion, Bayer, GSK, Pfizer, Gilead and Merck, during the conduct of the study. Conflict of interest: D. Pittrow reports receiving personal fees from Actelion, Aspen, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Novartis, Pfizer and AstraZeneca, outside the submitted work. Conflict of interest: C. Opitz reports receving personal fees from Actelion, Bayer, GSK, Pfizer and Novartis, during the conduct of the study. Conflict of interest: J.S.R. Gibbs reports receiving personal fees from Actelion, Bayer, GSK, Pfizer, MSD, Bellerophon and Arena, during the conduct of the study. Conflict of interest: S. Rosenkranz reports receving grants and personal fees from Actelion, Bayer, Pfizer, Novartis and United Therapeutics, and personal fees from GSK, Gilead and MSD, during the conduct of the study. Conflict of interest: E. Grünig reports receiving personal fees from Actelion, Bayer, GSK, Pfizer, United Therapeutics and MSD, outside the submitted work. Conflict of interest: K.M. Olsson reports receiving personal fees from Actelion, Bayer, GSK, Pfizer and United Therapeutics, during the conduct of the study. Conflict of interest: D. Huscher reports receiving personal fees from Actelion outside the submitted work.

Comment in

Risk assessment in pulmonary arterial hypertension.
Boucly A, Weatherald J, Humbert M, Sitbon O. Boucly A, et al. Eur Respir J. 2018 Mar 29;51(3):1800279. doi: 10.1183/13993003.00279-2018. Print 2018 Mar. Eur Respir J. 2018. PMID: 29599118 No abstract available.

Comment on

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
Hoeper MM, Kramer T, Pan Z, Eichstaedt CA, Spiesshoefer J, Benjamin N, Olsson KM, Meyer K, Vizza CD, Vonk-Noordegraaf A, Distler O, Opitz C, Gibbs JSR, Delcroix M, Ghofrani HA, Huscher D, Pittrow D, Rosenkranz S, Grünig E. Hoeper MM, et al. Eur Respir J. 2017 Aug 3;50(2):1700740. doi: 10.1183/13993003.00740-2017. Print 2017 Aug. Eur Respir J. 2017. PMID: 28775047
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.
Boucly A, Weatherald J, Savale L, Jaïs X, Cottin V, Prevot G, Picard F, de Groote P, Jevnikar M, Bergot E, Chaouat A, Chabanne C, Bourdin A, Parent F, Montani D, Simonneau G, Humbert M, Sitbon O. Boucly A, et al. Eur Respir J. 2017 Aug 3;50(2):1700889. doi: 10.1183/13993003.00889-2017. Print 2017 Aug. Eur Respir J. 2017. PMID: 28775050

Cited by

What's new in pulmonary hypertension clinical research: lessons from the best abstracts at the 2020 American Thoracic Society International Conference.
Sweatt AJ, Reddy R, Rahaghi FN, Al-Naamani N; American Thoracic Society Pulmonary Circulation Assembly Early Career Working Group. Sweatt AJ, et al. Pulm Circ. 2021 Aug 25;11(3):20458940211040713. doi: 10.1177/20458940211040713. eCollection 2021 Jul-Sep. Pulm Circ. 2021. PMID: 34471517 Free PMC article.
Risk assessment in precapillary pulmonary hypertension: a comparative analysis.
Sonnweber T, Schneider EM, Nairz M, Theurl I, Weiss G, Tymoszuk P, Löffler-Ragg J. Sonnweber T, et al. Respir Res. 2021 Jan 21;22(1):28. doi: 10.1186/s12931-021-01624-z. Respir Res. 2021. PMID: 33478493 Free PMC article.
The haemodynamic assessment of patients with pulmonary arterial hypertension.
Ghio S. Ghio S. Glob Cardiol Sci Pract. 2020 Apr 30;2020(1):e202004. doi: 10.21542/gcsp.2020.4. Glob Cardiol Sci Pract. 2020. PMID: 33150149 Free PMC article. Review. No abstract available.
ER-stress-induced secretion of circulating glucose-regulated protein 78kDa (GRP78) ameliorates pulmonary artery smooth muscle cell remodelling.
Al Zaidi M, Pizarro C, Bley C, Repges E, Sedaghat A, Zimmer S, Jansen F, Tiyerili V, Nickenig G, Skowasch D, Aksoy A. Al Zaidi M, et al. Cell Stress Chaperones. 2022 Sep;27(5):561-572. doi: 10.1007/s12192-022-01292-y. Epub 2022 Aug 27. Cell Stress Chaperones. 2022. PMID: 36029373 Free PMC article.
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension.
Hoeper MM, Pausch C, Olsson KM, Huscher D, Pittrow D, Grünig E, Staehler G, Vizza CD, Gall H, Distler O, Opitz C, Gibbs JSR, Delcroix M, Ghofrani HA, Park DH, Ewert R, Kaemmerer H, Kabitz HJ, Skowasch D, Behr J, Milger K, Halank M, Wilkens H, Seyfarth HJ, Held M, Dumitrescu D, Tsangaris I, Vonk-Noordegraaf A, Ulrich S, Klose H, Claussen M, Lange TJ, Rosenkranz S. Hoeper MM, et al. Eur Respir J. 2022 Jul 7;60(1):2102311. doi: 10.1183/13993003.02311-2021. Print 2022 Jul. Eur Respir J. 2022. PMID: 34737226 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Risk assessment in pulmonary arterial hypertension

Affiliations

Risk assessment in pulmonary arterial hypertension

Authors

Affiliations

Conflict of interest statement

Comment in

Comment on

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Conflict of interest statement

Comment in

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical